{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:05:26Z","timestamp":1790809526063,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08570-8","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:25:32Z","timestamp":1783347932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comprehensive plasma-based approach to thromboinflammation in bladder cancer: integrating lipidomics, thrombin generation, and NETosis biomarkers"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3963-8661","authenticated-orcid":false,"given":"Julia","family":"Oto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3838-097X","authenticated-orcid":false,"given":"Alejandro","family":"Herreros-Pomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8768-331X","authenticated-orcid":false,"given":"Patricia","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0894-2946","authenticated-orcid":false,"given":"Raquel","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-6984","authenticated-orcid":false,"given":"Emma","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"P\u00e9rez-Ardav\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar D.","family":"Vera-Donoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mart\u00ednez-Sarmiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Bonanad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9637-5998","authenticated-orcid":false,"given":"Pilar","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"3","key":"8570_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2024, May, 1;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clinicians"},{"issue":"6","key":"8570_CR2","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3390\/cancers13061448","volume":"13","author":"R Herranz","year":"2021","unstructured":"Herranz R, Oto J, Plana E, Fern\u00e1ndez-Pardo \u00c1, Cana F, Mart\u00ednez-Sarmiento M, et al. Circulating cell-free DNA in liquid biopsies as potential biomarker for bladder cancer: a systematic review. Cancers (Basel). 2021, Mar, 22;13(6):1448. https:\/\/doi.org\/10.3390\/cancers13061448.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"8570_CR3","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s00345-022-04136-7","volume":"40","author":"J Oto","year":"2022","unstructured":"Oto J, Fern\u00e1ndez-Pardo \u00c1, Roca M, Plana E, Cana F, Herranz R, et al. LC\u2013MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer. World J Urol. 2022;40(10):2387\u201398. https:\/\/doi.org\/10.1007\/s00345-022-04136-7.","journal-title":"World J Urol"},{"issue":"1","key":"8570_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40164-025-00649-0","volume":"14","author":"J Oto","year":"2025","unstructured":"Oto J, Herranz R, Plana E, P\u00e9rez-Ardav\u00edn J, Herv\u00e1s D, Cana F, et al. Validation of a microRNA profile in urine liquid biopsy with diagnostic and stratification value for bladder cancer classification, available through the open app BladdermiRaCan. Exp Hematol Oncol. 2025;14(1):58. https:\/\/doi.org\/10.1186\/s40164-025-00649-0.","journal-title":"Exp Hematol Oncol"},{"issue":"12","key":"8570_CR5","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jmoldx.2025.08.010","volume":"27","author":"R Herranz","year":"2025","unstructured":"Herranz R, Oto J, Plana E, P\u00e9rez-Ardav\u00edn J, Verger P, Mart\u00ednez-Sarmiento M, et al. Analysis of the Fragmentation and Integrity of urine cell-free DNA as a diagnostic and staging biomarker for bladder cancer. The J Mol Diagn. 2025;27(12):1189\u2013201. https:\/\/doi.org\/10.1016\/j.jmoldx.2025.08.010.","journal-title":"The J Mol Diagn"},{"issue":"1","key":"8570_CR6","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s12967-025-06749-z","volume":"23","author":"I Pagano","year":"2025","unstructured":"Pagano I, Zhang Z, Luu M, Tikhonenkov S, Le Calvez-Kelm F, Goodison S, et al. Performance of the oncuria-detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting. J Transl Med. 2025, Jun, 18;23(1):680. https:\/\/doi.org\/10.1186\/s12967-025-06749-z.","journal-title":"J Transl Med"},{"key":"8570_CR7","doi-asserted-by":"publisher","first-page":"116312","DOI":"10.1016\/j.biopha.2024.116312","volume":"173","author":"J Fan","year":"2024","unstructured":"Fan J, Chen B, Luo Q, Li J, Huang Y, Zhu M, et al. Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer. Biomed Pharmacother. 2024;173:116312. https:\/\/doi.org\/10.1016\/j.biopha.2024.116312.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8570_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41467-021-27765-9","volume":"13","author":"D Wolrab","year":"2022","unstructured":"Wolrab D, Jir\u00e1sko R, C\u00edfkov\u00e1 E, H\u00f6ring M, Mei D, Chocholou\u0161kov\u00e1 M, et al. Lipidomic profiling of human serum enables detection of pancreatic cancer. Nat Commun. 2022;13(1):124. https:\/\/doi.org\/10.1038\/s41467-021-27765-9.","journal-title":"Nat Commun"},{"issue":"1","key":"8570_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41391-023-00666-2","volume":"27","author":"T Scheinberg","year":"2024","unstructured":"Scheinberg T, Lin HM, Fitzpatrick M, Azad AA, Bonnitcha P, Davies A, et al. Pcpro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer. Prostate Cancer Prostatic Dis. 2024;27(1):136\u201343. https:\/\/doi.org\/10.1038\/s41391-023-00666-2.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"8570_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.euf.2017.04.005","volume":"4","author":"DWB Piyarathna","year":"2018","unstructured":"Piyarathna DWB, Rajendiran TM, Putluri V, Vantaku V, Soni T, von Rundstedt FC, et al. Distinct lipidomic landscapes associated with clinical stages of Urothelial cancer of the bladder. Eur Urology Focus. 2018, Dec, 1;4(6):907\u201315. https:\/\/doi.org\/10.1016\/j.euf.2017.04.005.","journal-title":"Eur Urology Focus"},{"issue":"12","key":"8570_CR11","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1158\/1078-0432.CCR-18-1515","volume":"25","author":"V Vantaku","year":"2019","unstructured":"Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, et al. Multi-omics integration analysis robustly predicts high-grade patient survival and Identifies CPT1B effect on fatty acid metabolism in bladder cancer. Clin Cancer Res. 2019, Jun, 14;25(12):3689\u2013701. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1515.","journal-title":"Clin Cancer Res"},{"key":"8570_CR12","doi-asserted-by":"publisher","unstructured":"Feng C, Pan L, Tang S, He L, Wang X, Tao Y, et al. Integrative transcriptomic, Lipidomic, and metabolomic analysis reveals potential biomarkers of basal and luminal muscle invasive bladder cancer subtypes. Front Genet. 2021, Aug, 16;12. https:\/\/doi.org\/10.3389\/fgene.2021.695662.","DOI":"10.3389\/fgene.2021.695662"},{"issue":"6","key":"8570_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/metabo12060544","volume":"12","author":"KR Kami Reddy","year":"2022","unstructured":"Kami Reddy KR, Piyarathna DWB, Kamal AHM, Putluri V, Ravi SS, Bollag RJ, et al. Lipidomic profiling Identifies a novel lipid signature associated with ethnicity-specific disparity of bladder cancer. Metabolites. 2022, Jun, 14;12(6):544. https:\/\/doi.org\/10.3390\/metabo12060544.","journal-title":"Metabolites"},{"issue":"7","key":"8570_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.114.301597","volume":"114","author":"VB O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell VB, Murphy RC, Watson SP. Platelet Lipidomics. Circ Res. 2014, Mar, 28;114(7):1185\u2013203. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.301597.","journal-title":"Circ Res"},{"issue":"8\u20139","key":"8570_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ejcb.2014.07.005","volume":"93","author":"A Neumann","year":"2014","unstructured":"Neumann A, Brogden G, Jerjomiceva N, Brodesser S, Naim HY, von K\u00f6ckritz-Blickwede M. Lipid alterations in human blood-derived neutrophils lead to formation of neutrophil extracellular traps. Eur J Cell Biol. 2014;93(8\u20139):347\u201354. https:\/\/doi.org\/10.1016\/j.ejcb.2014.07.005.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"8570_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/rth2.12018","volume":"1","author":"H Deguchi","year":"2017","unstructured":"Deguchi H, Navarro S, Payne AB, Elias DJ, Dowling NF, Austin HD, et al. Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases. Res Pract Thromb Haemostasis. 2017, Jul;1(1):33\u201340. https:\/\/doi.org\/10.1002\/rth2.12018.","journal-title":"Res Pract Thromb Haemostasis"},{"issue":"6","key":"8570_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s12276-023-01018-9","volume":"55","author":"M Lee","year":"2023","unstructured":"Lee M, Lee SY, Bae YS. Functional roles of sphingolipids in immunity and their implication in disease. Exp Mol Med. 2023;55(6):1110\u201330. https:\/\/doi.org\/10.1038\/s12276-023-01018-9.","journal-title":"Exp Mol Med"},{"issue":"6","key":"8570_CR18","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","volume":"21","author":"A Falanga","year":"2023","unstructured":"Falanga A, Marchetti M. Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemostasis. 2023, Jun, 1;21(6):1397\u2013408. https:\/\/doi.org\/10.1016\/j.jtha.2023.02.029.","journal-title":"J Thromb Haemostasis"},{"key":"8570_CR19","doi-asserted-by":"publisher","unstructured":"Herranz R, Oto J, Hueso M, Plana E, Cana F, Casta\u00f1o M, et al. Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro. Front Immunol. 2023, May, 19;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1171065.","DOI":"10.3389\/fimmu.2023.1171065"},{"key":"8570_CR20","unstructured":"Mostofi FK, Sobin LH, Torloni H, World Health Organization. Histological typing of urinary bladder tumours \/ F. K. Mostofi in collaboration with L. H. Sobin, H. Torloni and pathologists in fourteen countries. Geneva: World Health Organization; 1973. (International histological classification of tumours, no. 10). https:\/\/iris.who.int\/handle\/10665\/41533."},{"issue":"2","key":"8570_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/106689690501300203","volume":"13","author":"R Montironi","year":"2005","unstructured":"Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol. 2005, Apr, 1;13(2):143\u201353. https:\/\/doi.org\/10.1177\/106689690501300203.","journal-title":"Int J Surg Pathol"},{"issue":"20","key":"8570_CR22","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1093\/bioinformatics\/btac581","volume":"38","author":"MI Alcoriza-Balaguer","year":"2022","unstructured":"Alcoriza-Balaguer MI, Garc\u00eda-Ca\u00f1averas JC, Ripoll-Esteve FJ, Roca M, Lahoz A. LipidMS 3.0: an R-package and a web-based tool for LC-MS\/MS data processing and lipid annotation. Bioinformatics. 2022, Oct, 15;38(20):4826\u201328. https:\/\/doi.org\/10.1093\/bioinformatics\/btac581.","journal-title":"Bioinformatics"},{"issue":"3","key":"8570_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/ijms21030840","volume":"21","author":"J Oto","year":"2020","unstructured":"Oto J, Navarro S, Larsen AC, Solmoirago MJ, Plana E, Herv\u00e1s D, et al. MicroRNAs and neutrophil activation markers predict venous thrombosis in pancreatic ductal adenocarcinoma and distal extrahepatic cholangiocarcinoma. IJMS. 2020, Jan, 28;21(3):840. https:\/\/doi.org\/10.3390\/ijms21030840.","journal-title":"IJMS"},{"issue":"6","key":"8570_CR24","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/cancers12061536","volume":"12","author":"J Oto","year":"2020","unstructured":"Oto J, Plana E, Solmoirago MJ, Fern\u00e1ndez-Pardo \u00c1, Herv\u00e1s D, Cana F, et al. microRNAs and markers of neutrophil activation as predictors of early incidental post-surgical pulmonary embolism in patients with intracranial tumors. Cancers (Basel). 2020, Jun, 11;12(6):1536. https:\/\/doi.org\/10.3390\/cancers12061536.","journal-title":"Cancers (Basel)"},{"issue":"16","key":"8570_CR25","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.3390\/ijms21165651","volume":"21","author":"L Martos","year":"2020","unstructured":"Martos L, Oto J, Fern\u00e1ndez-Pardo \u00c1, Plana E, Solmoirago MJ, Cana F, et al. Increase of neutrophil activation markers in venous thrombosis\u2014contribution of circulating activated protein C. IJMS. 2020, Aug, 6;21(16):5651. https:\/\/doi.org\/10.3390\/ijms21165651.","journal-title":"IJMS"},{"issue":"6","key":"8570_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3324\/haematol.2019.240226","volume":"106","author":"AB Arroyo","year":"2020","unstructured":"Arroyo AB, Fern\u00e1ndez-P\u00e9rez MP, Del Monte A, \u00c1guila S, M\u00e9ndez R, Hern\u00e1ndez-Antol\u00edn R, et al. miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis. Haematologica. 2020, Jun, 1;106(6):1636\u201346. https:\/\/doi.org\/10.3324\/haematol.2019.240226.","journal-title":"Haematologica"},{"key":"8570_CR27","doi-asserted-by":"publisher","unstructured":"Oto J, Herranz R, Fuertes M, Plana E, Verger P, Baixauli F, et al. Dysregulated neutrophil extracellular traps and haemostatic biomarkers as diagnostic tools and therapeutic targets in periprosthetic joint infection. Bone Joint J. 2024, Sep;106-B;106-B(9):1021\u201330. https:\/\/doi.org\/10.1302\/0301-620X.106B9.BJJ-2024-0187.R1.","DOI":"10.1302\/0301-620X.106B9.BJJ-2024-0187.R1"},{"key":"8570_CR28","doi-asserted-by":"publisher","unstructured":"Tom\u00e1s-P\u00e9rez S, Oto J, Aghababyan C, Herranz R, Cuadros-Lozano A, Gonz\u00e1lez-Cant\u00f3 E, et al. Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients\u2019 biofluids: potential role in disease diagnosis and management. Front Immunol. 2023;14:1111344. https:\/\/doi.org\/10.3389\/fimmu.2023.1111344.","DOI":"10.3389\/fimmu.2023.1111344"},{"issue":"6","key":"8570_CR29","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","volume":"74","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urology. 2018, Dec;74(6):784\u201395. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.001.","journal-title":"Eur Urology"},{"issue":"1","key":"8570_CR30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/s12967-025-06542-y","volume":"23","author":"J Yu","year":"2025","unstructured":"Yu J, Xu H, Xiong F, Liu X, Lingfei M, Gao H, et al. Lipidomics reveals biomarkers of the efficacy of first-line ICI therapy combined with chemotherapy in NSCLC. J Transl Med. 2025, Jun, 10;23(1):638. https:\/\/doi.org\/10.1186\/s12967-025-06542-y.","journal-title":"J Transl Med"},{"issue":"1","key":"8570_CR31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1186\/s12967-025-06882-9","volume":"23","author":"M Yang","year":"2025","unstructured":"Yang M, Pang D, Gong C, Song K, Ma H, Yang Y, et al. GPD1L as a potential biomarker associated with Treg cell infiltration and lipid metabolism in clear cell renal cell carcinoma. J Transl Med. 2025, Aug, 6;23(1):872. https:\/\/doi.org\/10.1186\/s12967-025-06882-9.","journal-title":"J Transl Med"},{"issue":"17","key":"8570_CR32","doi-asserted-by":"publisher","first-page":"13231","DOI":"10.18632\/oncotarget.24229","volume":"9","author":"MY Lee","year":"2018","unstructured":"Lee MY, Yeon A, Shahid M, Cho E, Sairam V, Figlin R, et al. Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance. Oncotarget. 2018, Mar, 2;9(17):13231\u201343. https:\/\/doi.org\/10.18632\/oncotarget.24229.","journal-title":"Oncotarget"},{"issue":"1","key":"8570_CR33","doi-asserted-by":"publisher","first-page":"15156","DOI":"10.1038\/s41598-022-19576-9","volume":"12","author":"J Nizio\u0142","year":"2022","unstructured":"Nizio\u0142 J, Ossoli\u0144ski K, P\u0142aza-Altamer A, Ko\u0142odziej A, Ossoli\u0144ska A, Ossoli\u0144ski T, et al. Untargeted ultra-high-resolution mass spectrometry metabolomic profiling of blood serum in bladder cancer. Sci Rep. 2022, Sep, 7;12(1):15156. https:\/\/doi.org\/10.1038\/s41598-022-19576-9.","journal-title":"Sci Rep"},{"issue":"6","key":"8570_CR34","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/cells10061472","volume":"10","author":"L Vecchi","year":"2021","unstructured":"Vecchi L, Ara\u00fajo TG, Azevedo FVPDV, Mota STS, \u00c1vila VDMR, Ribeiro MA, et al. Phospholipase A2 drives Tumorigenesis and cancer aggressiveness through its interaction with annexin A1. Cells. 2021, Jun, 11;10(6):1472. https:\/\/doi.org\/10.3390\/cells10061472.","journal-title":"Cells"},{"issue":"1","key":"8570_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mco2.27","volume":"2","author":"Y Fu","year":"2021","unstructured":"Fu Y, Zou T, Shen X, Nelson PJ, Li J, Wu C, et al. Lipid metabolism in cancer progression and therapeutic strategies. MedComm (Beijing). 2021, Mar, 24;2(1):27\u201359. https:\/\/doi.org\/10.1002\/mco2.27.","journal-title":"MedComm (Beijing)"},{"issue":"1","key":"8570_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BST20210579","volume":"50","author":"VB O\u2019Donnell","year":"2022","unstructured":"O\u2019Donnell VB. New appreciation for an old pathway: the lands cycle moves into new arenas in health and disease. Biochem Soc Trans. 2022, Feb, 28;50(1):1\u201311. https:\/\/doi.org\/10.1042\/BST20210579.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"8570_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12944-024-02121-0","volume":"23","author":"Y Takanashi","year":"2024","unstructured":"Takanashi Y, Kahyo T, Sekihara K, Kawase A, Setou M, Funai K. Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies. Lipids Health Dis. 2024, May, 25;23(1):154. https:\/\/doi.org\/10.1186\/s12944-024-02121-0.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"8570_CR38","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41419-024-07134-2","volume":"15","author":"J Armistead","year":"2024","unstructured":"Armistead J, H\u00f6pfl S, Goldhausen P, M\u00fcller-Hartmann A, Fahle E, Hatzold J, et al. A sphingolipid rheostat controls apoptosis versus apical cell extrusion as alternative tumour-suppressive mechanisms. Cell Death Dis. 2024, Oct, 14;15(10):746. https:\/\/doi.org\/10.1038\/s41419-024-07134-2.","journal-title":"Cell Death Dis"},{"key":"8570_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.thromres.2019.12.018","volume":"186","author":"M Lundbech","year":"2020","unstructured":"Lundbech M, Krag AE, Christensen TD, Hvas AM. Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients. Thromb Res. 2020, Feb;186:80\u201385. https:\/\/doi.org\/10.1016\/j.thromres.2019.12.018.","journal-title":"Thromb Res"},{"issue":"3","key":"8570_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/metabo14030173","volume":"14","author":"A Arendowski","year":"2024","unstructured":"Arendowski A. Matrix- and surface-assisted laser Desorption\/Ionization mass spectrometry Methods for urological cancer biomarker discovery\u2014metabolomics and lipidomics approaches. Metabolites. 2024, Mar, 20;14(3):173. https:\/\/doi.org\/10.3390\/metabo14030173.","journal-title":"Metabolites"},{"key":"8570_CR41","doi-asserted-by":"publisher","unstructured":"Liu X, Zhang M, Cheng X, Liu X, Sun H, Guo Z, et al. LC-MS-Based plasma metabolomics and lipidomics analyses for differential diagnosis of bladder cancer and renal cell carcinoma. Front Oncol. 2020, May, 15;10. https:\/\/doi.org\/10.3389\/fonc.2020.00717.","DOI":"10.3389\/fonc.2020.00717"},{"issue":"12","key":"8570_CR42","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1111\/jth.15880","volume":"20","author":"F Moik","year":"2022","unstructured":"Moik F, Ay C. Hemostasis and cancer: impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer. J Thromb Haemostasis. 2022, Dec, 1;20(12):2733\u201345. https:\/\/doi.org\/10.1111\/jth.15880.","journal-title":"J Thromb Haemostasis"},{"issue":"7","key":"8570_CR43","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1182\/blood.V97.7.1907","volume":"97","author":"H Deguchi","year":"2001","unstructured":"Deguchi H, Fernandez J, Pabinger I, Heit JA, Griffin JH. Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway. Blood. 2001, Apr, 1;97(7):1907\u201314. https:\/\/doi.org\/10.1182\/blood.V97.7.1907.","journal-title":"Blood"},{"issue":"13","key":"8570_CR44","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2015-03-636761","volume":"126","author":"H Deguchi","year":"2015","unstructured":"Deguchi H, Banerjee Y, Trauger S, Siuzdak G, Kalisiak E, Fern\u00e1ndez JA, et al. Acylcarnitines are anticoagulants that inhibit factor xa and are reduced in venous thrombosis, based on metabolomics data. Blood. 2015, Sep, 24;126(13):1595\u2013600. https:\/\/doi.org\/10.1182\/blood-2015-03-636761.","journal-title":"Blood"},{"key":"8570_CR45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jbior.2016.11.001","volume":"63","author":"MP Espaillat","year":"2017","unstructured":"Espaillat MP, Kew RR, Obeid LM. Sphingolipids in neutrophil function and inflammatory responses: mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Adv Biol Regul. 2017, Jan;63:140\u201355. https:\/\/doi.org\/10.1016\/j.jbior.2016.11.001.","journal-title":"Adv Biol Regul"},{"key":"8570_CR46","doi-asserted-by":"publisher","unstructured":"Sun G, Wang B, Wu X, Cheng J, Ye J, Wang C, et al. How do sphingosine-1-phosphate affect immune cells to resolve inflammation? Front Immunol. 2024, Feb, 28;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1362459.","DOI":"10.3389\/fimmu.2024.1362459"},{"issue":"1","key":"8570_CR47","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1038\/s41467-023-41462-9","volume":"14","author":"M Oh","year":"2023","unstructured":"Oh M, Jang SY, Lee JY, Kim JW, Jung Y, Kim J, et al. The lipoprotein-associated phospholipase A2 inhibitor darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism. Nat Commun. 2023, Sep, 15;14(1):5728. https:\/\/doi.org\/10.1038\/s41467-023-41462-9.","journal-title":"Nat Commun"},{"issue":"1","key":"8570_CR48","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.1038\/s41598-024-57028-8","volume":"14","author":"S La Monica","year":"2024","unstructured":"La Monica S, Vacondio F, Eltayeb K, Lodola A, Volta F, Viglioli M, et al. Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models. Sci Rep. 2024, Mar, 18;14(1):6491. https:\/\/doi.org\/10.1038\/s41598-024-57028-8.","journal-title":"Sci Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08570-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:33:35Z","timestamp":1790807615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08570-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8570"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08570-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional ethics committee of La Fe University and Polytechnic Hospital (refs. 2014\/0314 and 2020\u2013101-1). Written informed consent was obtained from all participants. The study was conducted in accordance with the principles of the Declaration of Helsinki (Edinburgh amendment, 2000).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1224"}}